Pancreatic Cancer Research

ResearcherFred Hutch Cancer CenterActive in the last 2 years

Sita Kugel

Matched on ORCID iD 0000-0001-7202-187X; OpenAlex author ID A5034075190; NIH RePORTER profile ID 11787688. Sources: funder_awards.

Their work

Papers
9 (first author 0, last author 4)
Trials
0
Grants
4
Labs led
2
Collaborators
43
Papers, trials and grants by year

2016: 1 paper, 1 grant · 2017: none · 2018: none · 2019: 1 grant · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 3 papers, 1 grant · 2026: 5 papers, 1 grant

Papers 9

  1. ZNF274 constrains lineage plasticity and drives intrinsic resistance to CDK7 inhibitors in pancreatic cancer. Last author DOI 10.1038/s41467-026-73380-x↗
  2. MondoA mediates transcriptional coordination between the MYC network and the integrated stress response in pancreatic cancer. Co-author DOI 10.1073/pnas.2524659123↗
  3. Phase 2 study of azacitidine plus pembrolizumab as second-line treatment in patients with locally advanced or metastatic pancreatic ductal adenocarcinoma. Co-author DOI 10.1093/oncolo/oyag091↗
  4. Phase II Study of Pegvorhyaluronidase Alfa (PEGPH20) and Pembrolizumab for Patients with Hyaluronan-High, Pretreated Metastatic Pancreatic Ductal Adenocarcinom… Co-author DOI 10.3390/cancers18030507↗
  5. HMGA2 Expression in Pancreatic Ductal Adenocarcinoma Controls Tumor Microenvironment and Immunosuppression via IL1α Last author DOI 10.64898/2026.10.02.754697↗
  6. Long-Term Survival Following Chemoradiation in Locoregional Recurrent Germline ATM Mutated Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1016/j.adro.2025.101742↗
  7. HMGA2 and protein leucine methylation drive pancreatic cancer lineage plasticity. Last author DOI 10.1038/s41467-025-60129-1↗
  8. HMGA2 Expression Predicts Subtype, Survival, and Treatment Outcome in Pancreatic Ductal Adenocarcinoma. Last author DOI 10.1158/1078-0432.ccr-24-2200↗
  9. SIRT6 Suppresses Pancreatic Cancer through Control of Lin28b. Co-author DOI 10.1016/j.cell.2016.04.033↗

Grants 4

  1. Unraveling the role of LIN28B/HMGA2 axis in pancreatic cancer lineage plasticity AWARD pancan:2026-sita-kugel-phd-unraveling-the-role-of-lin28b-hmga2-axis
  2. Exploring the epigenetic control of pancreatic cancer subtypes R37CA241472↗
  3. Deciphering the role of Lin28b in pancreatic cancer to guide therapeutic discovery R00CA208032↗
  4. Deciphering the role of Lin28b in pancreatic cancer to guide therapeutic discovery K99CA208032↗

Closest collaborators

The 25 strongest of 43 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Stephanie Dobersch · 5 shared papers, 2025–2026 · strength 1.15
  2. Naomi Yamamoto · 5 shared papers, 2025–2026 · strength 1.09
  3. Rachael Ann Safyan · 4 shared papers, 2025–2026 · strength 0.92
  4. Faiyaz Notta · 4 shared papers, 2025–2026 · strength 0.83
  5. Elena Gabriela Chiorean · 3 shared papers, 2025–2026 · strength 0.66
  6. Sunil R. Hingorani · 3 shared papers, 2025–2026 · strength 0.64
  7. Adrianne Wallace-Povirk · 2 shared papers, 2026 · strength 0.45
  8. Nina G. Steele · 2 shared papers, 2025–2026 · strength 0.41
  9. Ian M. Loveless · 2 shared papers, 2025–2026 · strength 0.41
  10. Howard C. Crawford · 2 shared papers, 2025–2026 · strength 0.41
  11. Patrick A. Carroll · 1 shared paper, 2026 · strength 0.32
  12. Erin L. Ramsey · 1 shared paper, 2026 · strength 0.32
  13. Susan Elaine Bates · 1 shared paper, 2026 · strength 0.26
  14. Ruth Aroon White · 1 shared paper, 2026 · strength 0.26
  15. Jacob K.R. Jamison · 1 shared paper, 2026 · strength 0.26
  16. Tamas A. Gonda · 1 shared paper, 2026 · strength 0.26
  17. Gulam Abbas Manji · 1 shared paper, 2026 · strength 0.26
  18. Paul E. Oberstein · 1 shared paper, 2026 · strength 0.26
  19. Venu Gopal Pillarisetty · 1 shared paper, 2025 · strength 0.24
  20. Jonathan G. Sham · 1 shared paper, 2025 · strength 0.24
  21. Dushyant V. Sahani · 1 shared paper, 2025 · strength 0.24
  22. Martin C. Whittle · 1 shared paper, 2026 · strength 0.23
  23. Sabrina Ge · 1 shared paper, 2026 · strength 0.23
  24. Jessica E. Gianopulos · 1 shared paper, 2026 · strength 0.23
  25. Andrew Eugene Hendifar · 1 shared paper, 2026 · strength 0.23

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.